BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 24549857)

  • 1. siRNA combinations mediate greater suppression of hepatitis B virus replication in mice.
    Li G; Fu L; Jiang J; Ping Y; Huang Y; Wang Y
    Cell Biochem Biophys; 2014 Jul; 69(3):641-7. PubMed ID: 24549857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination therapy of siRNAs mediates greater suppression on hepatitis B virus cccDNA in HepG2.2.15 cell.
    Xin XM; Li GQ; Guan XR; Li D; Xu WZ; Jin YY; Gu HX
    Hepatogastroenterology; 2008; 55(88):2178-83. PubMed ID: 19260501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of hepatitis B virus cccDNA by siRNA in transgenic mice.
    Li G; Jiang G; Lu J; Chen S; Cui L; Jiao J; Wang Y
    Cell Biochem Biophys; 2014 Jul; 69(3):649-54. PubMed ID: 24569930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination of small interfering RNAs mediates greater inhibition of human hepatitis B virus replication and antigen expression.
    Chen Z; Xu ZF; Ye JJ; Yao HP; Zheng S; Ding JY
    J Zhejiang Univ Sci B; 2005 Apr; 6(4):236-41. PubMed ID: 15754419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5'-triphosphate-siRNA activates RIG-I-dependent type I interferon production and enhances inhibition of hepatitis B virus replication in HepG2.2.15 cells.
    Chen X; Qian Y; Yan F; Tu J; Yang X; Xing Y; Chen Z
    Eur J Pharmacol; 2013 Dec; 721(1-3):86-95. PubMed ID: 24099962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study of the efficacy of combination therapy of SiRNAs in HepG2.2.15 cells.
    Li GQ; Yu DM; Lu J; Chen SL; Zhao JY; Wang YC
    Hepatogastroenterology; 2011; 58(106):570-4. PubMed ID: 21661433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Inhibition of hepatitis B virus by combined siRNAs in vitro].
    Ye JJ; Xu ZF; Chen Z; Cao J; Zheng S; Ding JY
    Shi Yan Sheng Wu Xue Bao; 2005 Apr; 38(2):141-7. PubMed ID: 16011247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination of small interfering RNAs mediates greater suppression on hepatitis B virus cccDNA in HepG2.2.15 cells.
    Xin XM; Li GQ; Jin YY; Zhuang M; Li D
    World J Gastroenterol; 2008 Jun; 14(24):3849-54. PubMed ID: 18609708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis B virus is inhibited by RNA interference in cell culture and in mice.
    Ying RS; Zhu C; Fan XG; Li N; Tian XF; Liu HB; Zhang BX
    Antiviral Res; 2007 Jan; 73(1):24-30. PubMed ID: 16844238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific anti-viral effects of RNA interference on replication and expression of hepatitis B virus in mice.
    Wu Y; Huang AL; Tang N; Zhang BQ; Lu NF
    Chin Med J (Engl); 2005 Aug; 118(16):1351-6. PubMed ID: 16157029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis B surface antigen: relation to hepatitis B replication parameters in HBeAg-negative chronic hepatitis B.
    Manesis EK; Papatheodoridis GV; Tiniakos DG; Hadziyannis ES; Agelopoulou OP; Syminelaki T; Papaioannou C; Nastos T; Karayiannis P
    J Hepatol; 2011 Jul; 55(1):61-8. PubMed ID: 21145875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RNA interference inhibits hepatitis B virus gene expression and replication in HepG2-N10 cells.
    Ren JL; Pan JS; Cheng T; Dong J; Lu YP; Huang SJ; Shi HX; Wang L; Lian YM
    Chin J Dig Dis; 2006; 7(4):230-6. PubMed ID: 17054586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Curcumin inhibits hepatitis B virus infection by down-regulating cccDNA-bound histone acetylation.
    Wei ZQ; Zhang YH; Ke CZ; Chen HX; Ren P; He YL; Hu P; Ma DQ; Luo J; Meng ZJ
    World J Gastroenterol; 2017 Sep; 23(34):6252-6260. PubMed ID: 28974891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Establishment of an HBV chronic hepatitis B infection mouse model by vivo transduction of HBV cccDNA].
    Zhao T; Li X; Yin W; Cai X; Zhang W; Chen F; Lai G; Huang A
    Zhonghua Gan Zang Bing Za Zhi; 2014 Apr; 22(4):260-5. PubMed ID: 25173223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activity of stabilized short interfering RNA in a mouse model of hepatitis B virus replication.
    Morrissey DV; Blanchard K; Shaw L; Jensen K; Lockridge JA; Dickinson B; McSwiggen JA; Vargeese C; Bowman K; Shaffer CS; Polisky BA; Zinnen S
    Hepatology; 2005 Jun; 41(6):1349-56. PubMed ID: 15880588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis B virus inhibition in mice by lentiviral vector mediated short hairpin RNA.
    Deng L; Li G; Xi L; Yin A; Gao Y; You W; Wang X; Sun B
    BMC Gastroenterol; 2009 Oct; 9():73. PubMed ID: 19804649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Inhibition of hepatitis B virus replication and expression by RNA interference in vitro].
    Zhu C; Fan XG; Li N; Ying RS; Tian XF
    Zhonghua Yi Xue Za Zhi; 2005 Sep; 85(35):2503-6. PubMed ID: 16321280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [An in vitro model of hepatitis B virus gene replication and expression in primary rat hepatocytes transfected with circular viral DNA].
    Yao YQ; Zhang DF; Luo Y; Zhang DZ; Huang AL; Wang B; Zhou WP; Ren H; Guo SH
    Zhonghua Gan Zang Bing Za Zhi; 2002 Aug; 10(4):275-8. PubMed ID: 12223138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation between intrahepatic hepatitis B virus cccDNA levels and other activity markers in patients with HBeAg-negative chronic hepatitis B infection.
    Guner R; Karahocagil M; Buyukberber M; Kandemir O; Ural O; Usluer G; Inan D; Koksal I; Baykam N; Hizel K; Yamazhan T; Esen S; Tasyaran MA
    Eur J Gastroenterol Hepatol; 2011 Nov; 23(12):1185-91. PubMed ID: 21934508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimal design and validation of antiviral siRNA for targeting hepatitis B virus.
    Fu J; Tang ZM; Gao X; Zhao F; Zhong H; Wen MR; Sun X; Song HF; Qian XH
    Acta Pharmacol Sin; 2008 Dec; 29(12):1522-8. PubMed ID: 19026173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.